Tag: high-risk PCI


New Clinical Publication: Long-Term Outcomes of Complex, High-Risk PCI Patients

Dr. Shon Chakrabarti shares information on a recent publication from the Journal of Interventional Cardiology by Dr. Francesco Burzotta and colleagues on data from the Roma-Verona Registry. This study examined the long-term outcomes of complex high-risk patients with multivessel disease who were considered unsuitable for surgery and received an Impella-supported Protected PCI. Dr. Burzotta and … Continue reading “New Clinical Publication: Long-Term Outcomes of Complex, High-Risk PCI Patients”

Protected PCI with Impella and Intravascular Lithotripsy with Shockwave

Dr. Robert Riley of Christ Hospital presents a high-risk PCI case that required hemodynamic support with the Impella CP heart pump and utilized intravascular lithotripsy with Shockwave for vascular access. Subscribe, or join the conversation by following us on Twitter: @ProtectedPCI NPS-196

High-Risk PCI with Impella 2.5

Dr. Muhammad Chaudhry of Aultman Hospital, Ohio, presents an emergent high-risk PCI case involving a 95% left main blockage along with a 80-90% blockage in the RCA and 100% distal RCA occlusion. The patient began experiencing severe chest pain and was evaluated for surgery. Shortly after, the patient went into asystole and CPR was initiated. … Continue reading “High-Risk PCI with Impella 2.5”

Developing a Protected PCI Algorithm

Dr. Hiram Bezerra explains how his team created a Protected PCI algorithm and got buy-in from the entire heart team. Dr. Hiram Bezerra of University Hospital, Cleveland, shares his success in developing a Protected PCI algorithm. He shares his experience in achieving consensus from the entire heart team, including interventional cardiologists, cardiothoracic surgeons, heart failure … Continue reading “Developing a Protected PCI Algorithm”

Safety and Feasibility of the Impella® Device in High-Risk Percutaneous Coronary Intervention

Reference: Ait Ichou J et al. Catheter Cardiovasc Interv [published online September 20, 2017]. Key Takeaways Hemodynamic support with the Impella® device is associated with low mortality and low adverse events in patients undergoing high-risk percutaneous coronary intervention (HRPCI), according to a systematic review. According to findings from a systematic review by Ichou et al, … Continue reading “Safety and Feasibility of the Impella® Device in High-Risk Percutaneous Coronary Intervention”